High-Purity Miltefosine API for Pharmaceutical Applications
Discover the leading source for pharmaceutical-grade Miltefosine, a vital API for treating tropical diseases and amoeba infections.
Get a Quote & SampleProduct Core Value
Miltefosine API
Miltefosine API, with its high purity exceeding 99%, is a critical active pharmaceutical ingredient essential for the formulation of treatments targeting leishmaniasis and certain amoeba infections. This compound is recognized for its oral administration efficacy, offering a convenient and effective therapeutic option.
- Miltefosine API pharmaceutical applications: Explore the detailed specifications and quality standards that make this API suitable for advanced pharmaceutical formulations.
- High purity miltefosine API pharmaceutical applications: Learn about the stringent quality control measures ensuring the reliability and effectiveness of this crucial medical compound.
- Miltefosine CAS 58066-85-6: Access comprehensive information on the chemical identity and regulatory compliance of this vital pharmaceutical ingredient.
- Oral treatment for leishmaniasis: Understand the clinical significance of Miltefosine API as a key component in oral treatment regimens for various forms of leishmaniasis.
Key Advantages
Exceptional Purity
Achieve superior therapeutic outcomes with Miltefosine API, boasting an assay of over 99%, ensuring the highest quality for your pharmaceutical products, directly impacting the effectiveness of your oral treatment for leishmaniasis.
Versatile Application
This API is a cornerstone in developing treatments for a spectrum of parasitic and amoebic infections, showcasing its broad miltefosine anti-protozoal activity and utility in modern medicine.
Reliable Supply Chain
Secure a consistent supply of this essential pharmaceutical grade miltefosine supplier, supported by robust production capacity and adherence to GMP and ISO standards.
Key Applications
Leishmaniasis Treatment
Discover how Miltefosine API is integral to advanced formulations for treating visceral, cutaneous, and mucosal leishmaniasis, a critical step in managing these tropical diseases.
Amoeba Infections Therapy
Explore the use of Miltefosine API in combatting rare but severe infections caused by free-living amoebas, highlighting its broad therapeutic potential.
Pharmaceutical Research & Development
Leverage the high purity and consistent quality of Miltefosine API in your research and development efforts for novel anti-infective agents.
Global Health Initiatives
Contribute to global health by utilizing Miltefosine API in the production of essential medicines for neglected tropical diseases, emphasizing its role as a key antiparasitic drug development compound.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).